Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.

Antiphospholipid antibodies are strongly associated with arterial and venous thrombosis and with fetal loss. Recently an experimental model for antiphospholipid syndrome (APLS) was established in our laboratory. In this model, mice are immunized passively or actively with anticardiolipin antibodies...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Fishman, P, Falach-Vaknine, E, Zigelman, R, Bakimer, R, Sredni, B, Djaldetti, M, Shoenfeld, Y
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 1993
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC288166/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8473523/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116396
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!